Ampio Pharmaceuticals
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $9,268,000.

Profit Margin

Ampio Pharmaceuticals, Inc. (AMEX:AMPE): Profit margin
2014 76.78K -38.12M -49650.87%
2015 1.16M -32.01M -2753.66%
2016 0 -19.16M
2017 0 -51.89M
2018 0 33.98M
2019 0 -8.68M
2020 0 -16.49M
2021 0 -12.48M
2022 0 -8.46M
2023 0 -8.63M

AMPE Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
000000001.16M76.78K
Cost of revenue
250K2.07M1.09M1.17M1.27M523K568K950K369.30K2.24M
Gross profit
-250K-2.07M-1.09M-1.17M-1.27M-523K-568K-950K793.15K-2.16M
Operating exp.
Research and development
2.43M8.91M11.9M9.17M12.62M6.82M10.42M10.54M18.96M26.92M
Selling and marketing
0000000000
Total operating expenses
9.26M20.38M20.57M15.83M18.57M11.18M15.56M17.08M34.09M39.14M
Operating income
-9.51M-24.20M-25.15M-15.21M-23.44M-11.18M-15.56M-17.08M-33.30M-39.07M
Other income (expenses), net
886K7.87M8.08M-60K9.81M45.17M-36.21M-2.10M-412.07K-7.60M
Income before tax
-8.63M-16.33M-17.07M-15.89M-13.63M33.98M-51.89M-19.16M-33.71M-39.04M
Income tax expense
0-7.87M-4.59M604K-4.94M45.17M36.32M1.03M-1.29M-923.52K
Net income
-8.63M-8.46M-12.48M-16.49M-8.68M33.98M-51.89M-19.16M-32.01M-38.12M
Earnings per share
Basic EPS
-10.67-11.24-18.79-28.63-18.3288.39-239.13-5.35-184.7-227.72
Diluted EPS
-10.66-11.24-18.59-27.71-18.3288.39-238.41-5.35-184.7-227.72
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source